112 related articles for article (PubMed ID: 8216559)
1. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5.
Tsai JJ; Yu LN; Wang SR
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):5-11. PubMed ID: 8216559
[TBL] [Abstract][Full Text] [Related]
2. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
3. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
Walsh GM; Hartnell A; Wardlaw AJ; Kurihara K; Sanderson CJ; Kay AB
Immunology; 1990 Oct; 71(2):258-65. PubMed ID: 2228026
[TBL] [Abstract][Full Text] [Related]
4. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3.
Blom M; Tool AT; Kok PT; Koenderman L; Roos D; Verhoeven AJ
Blood; 1994 May; 83(10):2978-84. PubMed ID: 8180394
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor increases expression of complement receptors on human neutrophils.
Shalit M; Von Allmen C; Atkins PC; Zweiman B
J Leukoc Biol; 1988 Sep; 44(3):212-7. PubMed ID: 2842423
[TBL] [Abstract][Full Text] [Related]
8. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
9. Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor.
Kato M; Kita H; Tachibana A; Hayashi Y; Tsuchida Y; Kimura H
Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():37-43. PubMed ID: 15166482
[TBL] [Abstract][Full Text] [Related]
10. A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils.
Thorne KJ; Richardson BA; Mazza G; Butterworth AE
J Immunol Methods; 1990 Oct; 133(1):47-54. PubMed ID: 2212691
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
12. Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat. Possible roles of interleukin 5 and platelet-activating factor.
Etienne A; Soulard C; Thonier F; Braquet P
Int Arch Allergy Appl Immunol; 1989; 88(1-2):216-21. PubMed ID: 2468617
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor primes human eosinophil generation of superoxide.
Zoratti EM; Sedgwick JB; Bates ME; Vrtis RF; Geiger K; Busse WW
Am J Respir Cell Mol Biol; 1992 Jan; 6(1):100-6. PubMed ID: 1309421
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils.
van der Bruggen T; Kok PT; Raaijmakers JA; Lammers JW; Koenderman L
J Immunol; 1994 Sep; 153(6):2729-35. PubMed ID: 8077677
[TBL] [Abstract][Full Text] [Related]
15. The effects of asthmatic mononuclear cell cultured supernatant on human eosinophils-chemiluminescence response, complement receptor expression and cellular density alteration.
Tsai JJ; Yu LN; Wang SR
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 May; 25(2):78-90. PubMed ID: 1473375
[TBL] [Abstract][Full Text] [Related]
16. Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles.
Blom M; Tool AT; Roos D; Verhoeven AJ
J Immunol; 1992 Dec; 149(11):3672-7. PubMed ID: 1431137
[TBL] [Abstract][Full Text] [Related]
17. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation.
Coyle AJ; Urwin SC; Page CP; Touvay C; Villain B; Braquet P
Eur J Pharmacol; 1988 Mar; 148(1):51-8. PubMed ID: 3383997
[TBL] [Abstract][Full Text] [Related]
18. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
Hartnell A; Robinson DS; Kay AB; Wardlaw AJ
Immunology; 1993 Oct; 80(2):281-6. PubMed ID: 8262555
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils.
van der Bruggen T; Kanters D; Tool AT; Raaijmakers JA; Lammers JW; Verhoeven AJ; Koenderman L
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):103-9. PubMed ID: 9449508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
